medical – FirmenBox.de

TissUse grants first Smart Hair Transplant (SHT) License in Japan

For the first time, TissUse has granted development and distribution rights of its existing Smart Hair Transplant (SHT) technology to J. Hewitt, a Japan-based biopharmaceutical company focused on creating transformative regenerative medicine for aesthetic surgery.

Under the terms of this agreement, TissUse grants J. Hewitt an exclusive license in Japan for the development of novel cell-based hair regeneration therapies leveraging TissUse’s SHT technology and expertise.

“We are excited to work with TissUse and the strategic license agreement is testament to our confidence in the value of the TissUse technologies. We look forward to a successful relationship with TissUse as we contribute to the further development of its SHT technology,” says Dr. Jon Knight, CEO of J. Hewitt.

“This agreement synergizes the complementary ideas, know-how and experience of both companies. We are very much looking forward to enhancing TissUse’s highly innovative SHT approach through this collaboration,” explains Dr. Uwe Marx, CEO of TissUse.

Technical and financial details of the collaboration were not disclosed.

About J. Hewitt – www.jhewitt.co.jp

J.Hewitt was established in Tokyo in February 1977 as an importer and distributor of medical devices and equipment. A management buyout completed in July 2004 by Jon Knight, redirected the company’s focus as a world pioneer into the field of aesthetic regenerative medicine. Dr. Knight conceptualized and invented the use of Platelet-Rich Plasma (PRP) for wrinkle augmentation and first in world use in humans for nasolabial folds, tear troughs, crow feet, and other facial wrinkles was performed in early 2005 and has been widely copied and is now a common therapy offered by most cosmetic surgeons and aesthetic dermatologists.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

The Future of Manufacturing at Hannover Messe

Critical Manufacturing is helping high-tech manufacturing companies optimize efficiency, enhance quality, reduce costs and make their businesses more agile with its ground-breaking Manufacturing Execution System (MES). It will be showcasing the enormous capability of this modern, Industry 4.0 ready, modular system at this year’s Hannover Messe from 1st to 5th April.

Critical Manufacturing MES has been designed for complex discrete industries including electronics, semiconductor and medical devices. Based on de-centralized logic, it enables the move to dynamic production models, where smart products and materials negotiate with intelligent machines to find the most efficient and economical route through the shop floor. The MES uses a breakthrough equipment integration and automation module, “Connect IoT” which simplifies the integration of all devices, equipment and the Internet of Things (IoT) and dramatically reduces the time and cost needed for companies to reap the tremendous benefits of smart technologies and Industry 4.0 manufacturing models.

The mission of Connect IoT is to dramatically reduce the time and effort to implement equipment or IoT integration. It reaches across all types of devices to create the Industry 4.0 decentralized autonomous shop floor marketplace. It’s a lightweight, low footprint solution to connect older, legacy equipment or new devices, any protocol.

Beyond that, Connect IoT has a single graphical view of all automation workflows. Engineers can create and update complex logic with no code required in an intuitive fashion. The system also allows visual debugging without external simulators. Once the power user develops a workflow, it’s reusable

The Connect IoT module is an exciting piece of forward-looking engineering. It enables easy integration of new and legacy equipment and devices to create a distributed, de-centralized architecture on which to build an autonomous production network using a drag-and-drop logic interface. Accommodating new and older technology, it provides a clear, straightforward pathway for companies to move towards Industry 4.0 at a pace that suits their business strategy. The module is intelligent, automatically abstracting workflow elements with specific drivers, and requires no coding to set up.

The Critical Manufacturing MES also incorporates digital twin technology to provide clear plant visualization, including detailed information on equipment, product and process key performance indicators (KPIs). At an execution level, this digital twin helps better utilize the huge amounts of data available from a smart shop floor to help increase operating efficiency and maximize the potential of assets.

The MES enables the easy creation of 3D models of the shop floor and can deliver further benefits to users through its virtual reality (VR) and augmented reality (AR) capability.

For manufacturers of sophisticated and complex product lines, there are enormous benefits in the move to Industry 4.0 technology. The Critical Manufacturing MES has been specifically designed to embrace the IoT, distributed intelligence and vertical integration of services required for a robust, highly efficient smart factory. At this exciting time in industrial history, the Critical Manufacturing MES provides the backbone needed to create a truly smart factory and a pathway for companies to reach new levels of efficiency and innovation that will keep their business strong and competitive into the future

Critical Manufacturing will be exhibiting at Hannover Messe from 1st-5th April 2019 at hall 7, stand 13, where experts will be on hand to discuss how this MES revolutionizes production capability. Visit www.criticalmanufacturing.com to schedule a meeting with Critical Manufacturing experts at the event.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Clean room workplace CleanBoy®

SPETEC GmbH in Erding is presenting a new product in the field of clean room technology. With CleanBoy®, users can achieve highly efficient clean room conditions at any workplace at little investment cost.

The need for extremely clean conditions is becoming ever more important in research and production as well as during service operations. The aim of clean room technology is to remove particles of a diameter of 0.12 µm or larger from a defined space in which the most exacting cleanliness standards guarantee a reliable workflow. This can be achieved using a clean room module from the SuSi® (Super Silent) series which is positioned directly above the work area. Exceptionally pure, filtered air is then passed over the work area. While the normal indoor atmosphere contains somewhere between 9,000 and 15,000 particles per liter, the use of clean room technology reduces this to a mere 3 particles per liter.

Parts or components produced in the mechanical engineering, electronics, optoelectronics, medical or biotechnology industries can be assembled or stored with exceptional reliability. A mobile, wheel-mounted version of the CleanBoy® makes it possible to transport the unit to different locations within the company. It is also possible to adapt the dimensions to meet the requirements of problematic workplaces.

The use of the CleanBoy® in large walk-in spaces results in a defined area in which practically no more particles can be detected. The unit is available in table-top and floor-standing versions. It requires no installation work and is ready for use immediately after delivery.

www.spetec.de

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

EXTEDO Announces Next Generation Pharmacovigilance Solution

EXTEDO, a leading provider of Regulatory Information Management solutions, today announced the release of their next generation pharmacovigilance and drug safety offerings.

EXTEDO SafetyEasy™ PV offering is a comprehensive and cost-effective solution designed to streamline pharmacovigilance processes within regulated organizations. It provides the ability to classify, create, review, submit and maintain pharmacovigilance data and adverse event reports within a single, easy-to-use application.

“SafetyEasy™ PV is the future of adverse event processing and safety monitoring”, said Christian Bohrmann, VP Marketing & Alliances at EXTEDO. “Over recent years we have seen an ever-growing demand for a cloud-based vigilance solution. So as we transition our safety database to the latest E2B(R3) standard we have chosen to partner with AB Cube, one of the leading SaaS safety database providers.”

Built specifically to support the E2B(R3) standard, SafetyEasy™ PV handles the reporting and management of all serious and non-serious adverse events. Its future-proof approach is able to generate documentation based around current safety standards and is ready for the arrival of IDMP.

EXTEDO also announced that they will be adding AB Cube’s other safety solutions for medical devices and cosmetics to their EXTEDOsuite portfolio in the coming months.

Pricing and Availability

SafetyEasy™ PV is available through EXTEDO from today and other safety database options will follow in the coming months. For further details visit www.extedo.com or contact your local EXTEDO account manager.

About AB Cube

AB Cube is a leading provider of SaaS-based pharmacovigilance and safety databases. Founded in Paris in 2006, their goal was to provide a centralised platform for management of safety information. Over the years the company has grown to encompass numerous different types of vigilance and the platform now supports over 100 customers, with 500 databases and more than 1,800 users worldwide.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Radiometer und Perimed schließen sich zusammen, um die Wundbehandlung und hyperbare Diagnostik zu verbessern

Radiometer Medical ApS (Radiometer) geht eine Partnerschaft mit Perimed AB ein. Ziel ist es, die Distribution des PeriFlux 6000 tcp0₂ Stand-alone-Systems zu beschleunigen und zu expandieren. Diese Partnerschaft vereint das starke, direkte und bewährte kommerzielle Netzwerk von Radiometer mit dem State-of-the-Art-System von Perimed. So profitiert eine größere Bandbreite von Kunden und Patienten von den Möglichkeiten des Produktes.

“Unsere Vision bei Radiometer ist, die globale Patientenversorgung durch zuverlässige, schnelle und einfache Diagnosen zu verbessern”, sagt Henrik Schimmell, Präsident und CEO von Radiometer. “Wir bemühen uns sehr, die Anforderungen unserer Kunden zu erfüllen und Erwartungen, wenn möglich, zu übertreffen. Das PeriFlux 6000 tcp0₂System zählt zu der neuesten Generation von transkutanen Monitoren. Wir freuen uns die Distributionsrechte für das Gerät zu erhalten, und seine Position im Markt weiter zu expandieren.”

Das Periflux 6000 tcp0₂ Stand-alone-System ergänzt das Portfolio transkutaner Monitoringsysteme von Radiometer für die nichtinvasive Bestimmung des Oxygenierungsstatus. Das PeriFlux 6000 tcp0₂ Stand-alone-System liefert medizinischem Fachpersonal ein zuverlässiges, bedienerfreundliches Werkzeug zur Unterstützung der Wundheilungsvorhersage und ersetzt den TCM400 Monitor von Radiometer.

“Die Mission von Perimed ist es, die Lebensqualität von Menschen mit vaskulären Erkrankungen zu verbessern. Perimed entwickelt diagnostische Instrumente im Bereich der Mikrozirkulation und der peripheren Makrozirkulation“, erklärt Björn Bakken, Präsident von Perimed. “Wir haben gute Produkte, aber unsere Vertriebskapazitäten sind begrenzt. Der Vertrieb und die tcp0₂-Kenntnisse von Radiometer sind unbestritten; deshalb freuen wir uns, diese Partnerschaft eingegangen zu sein. Wir hoffen, dass diese Kooperation zu einer Verbesserung der Diagnostik in der Wundpflege und im Sektor der hyperbaren Therapie beitragen wird.”

Das PeriFlux 6000 tcp0₂ Stand-alone-System wird zunächst in den Vereinigten Staaten gelauncht; andere Märkte folgen. Im Rahmen des Launches in den USA wird Radiometer den Support derzeitiger und künftiger Nutzer des PeriFlux 6000 tcp0₂ Stand-alone-Systems übernehmen.

Vertrieb und Support aller kartenbasierten Perimed PeriFlux 6000 Systeme, die einen PC beinhalten und den Blutdruck im Zeh, SPP bzw. tcp0₂ in Kombination mit dem Blutdruck im Zeh oder SPP bestimmen, obliegen weiterhin Perimed. Perimed unterstützt außerdem die älteren PeriFlux 5000 Systeme sowie die Perimed Imager Instrumente.

Über Perimed

Perimed ist ein globaler Marktführer in der Entwicklung, Herstellung und Vermarktung modernster Geräte für die mikrovaskuläre Diagnostik.
Perimed bietet Geräte, Software und Fachkenntnisse zur Beurteilung der Mikrozirkulation. Durch die Nutzung von Laser-Doppler, Laser-Speckle (LASCA) und transkutanem Sauerstoff (tcpO₂ der TCOM) überwacht und und misst Perimed Durchblutung und Sauerstoffsättigung des Gewebes in Echtzeit.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Critical Manufacturing Announces Significant Growth in Revenue and MES Orders

Critical Manufacturing, a leading developer of innovative, future-ready manufacturing execution system (MES) software, has announced 2018 end-of-year results, achieving 40% revenue growth and a remarkable 65% growth in product orders year over year. Its exceptional performance reflects the readiness of high-tech industries to adopt the huge benefits offered through Industry 4.0 (I4.0), smart factory technology.

Francisco Almada Lobo, CEO at Critical Manufacturing said, “The manufacturing landscape is undergoing significant changes and our MES is an essential element of our customers smart manufacturing strategy. The readiness of our MES for I4.0 makes it a compelling choice which is highly appealing to businesses. It is designed to provide them with a firm foundation and pathway to the huge benefits a smart factory offers in terms of greater efficiency, agility, and increased competitive edge.”

The Critical Manufacturing MES has seen great success and growth in its core market segments of electronics, front and back-end semiconductor and medical device manufacturing. The recent strategic investment in the business by ASMPT, the world’s largest hardware and software supplier to the electronics manufacturing industry, has further increased Critical Manufacturing’s global reach and financial strength.

Almada Lobo continued, “This is a very exciting time for us. Our orders increase means we are already on track for an exceptional 2019 and now, with the investment from ASMPT, we expect our growth and results going forward to be even stronger. We have also invested in our partner network, which is increasing our representation across adjacent industries such as automotive and aerospace. In response to the huge success we experienced last year, we increased our employee count by 30% in 2018 and will continue our expansion in all areas in 2019.”

Critical Manufacturing MES is designed from the ground up to be future ready and help businesses reach the full potential of I4.0. The modular system has a wide range of features to match specific customer requirements, is completely flexible and configurable to reduce total cost of ownership, and has advanced I4.0 capability. It offers a complete digital twin of a plant with 3D visualization. It provides decentralized logic to connect with the Internet of Things (IoT) and to seamlessly handle dynamic processing as associated with a smart factory.

Almada Lobo concluded, “Our MES is optimized for global, multi-site manufacturers, an area in which we have had a great deal of success during 2018. We will continue to focus and grow capabilities in our strategic markets and work with our partners to serve new business in adjacent sectors. The unique design and ultimate flexibility of our MES makes it a solid choice to increase efficiency, quality and agility in complex discrete manufacturing industries. It gives businesses the tools they need to meet changing customer demands and compete in the future.”

About ASM Pacific Technology Limited (ASMPT)
Headquartered in Singapore, ASMPT (HKEX stock code: 0522) is a global technology and market leader in leading edge solutions and materials for the semiconductor assembly and packaging industries. Its surface mount technology solutions are deployed in a wide range of end-user markets including electronics, mobile communications, automotive, industrial, LED and alternative energy. The company’s continuous investments in research and development help to provide its customers with innovative and cost-efficient solutions and systems that enable them to achieve higher productivity, greater reliability and enhanced quality.

For more information about ASMPT visit www.asmpacific.com

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Close to the Customer – ODU to expand market in Korea

As of January 1, 2019 ODU has established its newest ODU company in Korea. Kai Schneider is Managing Director of ODU Korea Inc. Together with the longstanding trading partners it is his task to further expand sales in Korea, to find new sales channels and to introduce ODU connector solutions into Korean medical technology and robotics. "Currently, we are strong in Korea, especially in the field of e-mobility and military technology. We also want to prove our know-how in new fields and applications", says Kai Schneider.

Schneider is a mechanical engineer and brings a lot of experience in mechanical engineering as well as his knowledge of Korean culture. With its new company, ODU wants to be ready and personally accessible to its customers and partners. Kai Schneider will act as the interface between Korea and ODU in Mühldorf (Bavaria). "We also care about the geographical closeness to the customer. We already are present in Japan and China, and that has proven to be successful", says Denis Giba, ODU Managing Director. As a specialist for electrical connector systems, ODU develops solutions exactly to customers’ requirements and specifications. In close cooperation ODU creates technically and economically optimal connector systems that meet the customer needs.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Smart Galvanometer Scanner for Medical and Scientific Applications

SCANLAB GmbH, market-leading OEM manufacturer of advanced laser scan systems, presents its latest offering in the galvanometer product range: the compact dynAXIS 421. The small sized galvo is especially suited to applications in the medical environment – from Optical Coherence Tomography (OCT) to microscopy, DNA-sequencing and other medical laser treatments. The superior motor design with analog or digital servo-control technology, together with ISO 9001-certified quality standards, guarantees highest reliability and extraordinary precision. Digital system monitoring and customizable feedback signals offer an appropriate solution for demanding bio-medical and industrial customers.

Medical applications have special requirements to ensure patient comfort and safety. Therefore precision and long-term reliability are particularly important. Improved scan efficiency, resulting in shorter treatment times and higher quality imaging are especially beneficial in the biomedical sector.

The new compact galvanometer scanner dynAXIS 421 meets the market needs at a reasonable cost target. When combined with SCANLAB’s digital servo-controller, the galvo provides highest dynamics. The new optical position detector results in superior precision and stability. System status monitoring is a flexible feature which can be tailored to the application needs. Low heat generation and optimized thermal resistance ease the integration into handheld devices or complex medical and ophthalmic instruments.

Thanks to SCANLAB’s lean organization, lead times are not only shorter than market average, but are highly dependable. ‘Made in Germany’ proves highest quality standards and consistency across the entire product range. Experienced sales engineers and an application support team provide quick and detailed responses, and customization as needed.

The compact dynAXIS 421 may be purchased with either analog or digital servo-driver boards and a large variety of mirrors and coating options. Standard configurations are available now.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Richard Wolf at ARAB HEALTH 2019

At ARAB HEALTH in Dubai from 28 to 31 January 2019, Richard Wolf GmbH will be presenting its innovative system solutions for minimally invasive human medicine, which visitors can experience both live and virtually. In addition to the classic product presentation, the medical technology company is increasingly focusing on the digital experience of its topics at trade fairs and congresses and will continue to expand this area in the future. Interested visitors can, for example, experience Richard Wolf’s high-resolution ENDOCAM Logic 4K camera system either in a virtual tour using VR glasses or inform themselves in the usual product exhibition. The area of extracorporeal shockwave lithotripsy (ESWL) can also be experienced via virtual reality (VR). During the VR tour, the visitor is in a treatment room equipped with a complete PiezoLith 3000plus system. During the simulation, the visitor has the possibility to virtually perform an ESWL on a patient with kidney stones. The treatment can be carried out either with ultrasound or X-ray imaging. The presentation of product solutions such as the network-based OR integration system core nova, the powerful Holmium:YAG laser MegaPulse 70+ and the innovative solutions for minimally invasive spinal surgery round out Richard Wolf’s overall presence at the largest and most important healthcare congress in the Middle East.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox

Medical Cannabis Products: How Much Really Gets There?

More and more companies and entrepreneurs operating in the field of Cannabis realize that while the market for ‘flowers’ and ‘extracts’ is significant (and likely to grow), the true ‘holy grail’ lies in the area of cannabis-based therapies.

Among the many questions faced by any company developing a new drug, probably the most complicated are those related to the behavior of their drug in the human body. This is the field of ADME: Absorption, Distribution, Metabolism and Excretion, or, in other words, “How much really gets there?” and where is actually “There”?

One of the tools for obtaining information related to the ADME behavior of the drug, is to determine the levels of compounds of interest in various biological tissues and fluids – i.e., Bioanalytics. In pre-clinical (animal) studies, this can include the analyses of plasma, urine, feces, skin, internal organs and brain. Clinical (human) studies usually include plasma, urine and feces. One of the greatest challenges of determining the levels of cannabinoids in the body, is the highly sensitive detection levels required.

Analyst Research Laboratories, with its more than 2 decades of experience in the Pharmaceutical, Bioanalytical and Analytical arena, is employing this vast experience to the area of Medical Cannabis.

With in-house validated Bioanalytical and Analytical methods for a variety of cannabinoids, species and tissues, Analyst is routinely supporting its customers from Israel and abroad in their Pre-Clinical and Clinical studies.

If you are developing a new formulation or product, planning a pre-clinical or clinical trial, we will be more than happy to discuss your needs and see if we can help you.

Originalmeldung direkt auf PresseBox lesen
Mehr von Firma PresseBox